CTT Pharma Files a Patent Continuation with the U.S. Patent Office

CTT Pharma Corporate Updates

CTT Pharma Receives U.S. Patent Approval for Nicotine, Vitamins, and Caffeine Delivery Technology

CTT Pharma Receives SEC Approval

CTT Pharma Signs LOI with European Company

CTT Pharmaceutical Holdings, Inc. Files Form S-1 Registration Statement and Advances Equity Line of Credit and Scientific Development Milestones

CTT Pharma's Scientists Publish Peer-Reviewed Paper in the Journal of Drug Delivery and Therapeutics

CTT Pharma's CEO will issue a Letter to Shareholders

CTT Pharma Signs Contract for $3 Million Equity Line of Credit